In tumors with increased expression of PD-L1, apart from the inhibition of T lymphocytes activity, a greater resistance of tumor cells to apoptosis was also found, which indicates an additional defense mechanism of tumors using the PD-1/PD-L pathway [5,18,19]. The gene discussed is PDCD1; the disease is neoplasm.